Acute treatment with monoclonal antibodies: their design and their use
Sign Up to like & getrecommendations! Published in 2021 at "Microbiology Australia"
DOI: 10.1071/ma21011
Abstract: Passive anti-viral immunotherapy, including monoclonal antibodies (mAb), was identified early as a promising therapeutic avenue for COVID-19 with a rapid development pathway. This has been driven by the lack of existing effective direct acting antivirals… read more here.
Keywords: treatment monoclonal; monoclonal antibodies; acute treatment; antibodies design ... See more keywords